Boston Strategics begins Phase I trial of anti-cancer agent to treat haematologic malignancies
Boston Strategics (BSC) has started a Phase I clinical trial of Fujifilm's anti-cancer agent FF-10501 in the US to treat patients with advanced haematologic...
Exelixis’ Phase III prostate cancer trial of cabozantinib fails to meet primary endpoint
US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of cabozantinib in men with...
Novartis to unveil new data from three key clinical trials at European Respiratory Society International Congress 2014
First presentation of LANTERN study to confirm superior efficacy of once-daily Ultibro® Breezhaler® versus Seretide® Accuhaler®* in COPD patients QUANTIFY study to show superiority...
InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®
InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for...
Asterias to begin AST-OPC1 Phase I/IIa trial to treat spinal cord injury
The US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa clinical trial of its...
Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function after Kidney Transplantation
Alexion Pharmaceuticals, Inc. today announced the initiation of dosing in a single, multinational, placebo-controlled clinical trial to evaluate the efficacy and safety of eculizumab...
FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJet’s Needle-Free Injector
PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...